Author details

Full Name

Gilbert Semana

Affiliation

ORCID

Career Start Year

1985

Papers

108

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
32522359	Corrigendum to "A new set of reagents and related software used for NGS based classical and non-classical HLA typing showing evidence for a greater HLA haplotype diversity" [Hum. Immunol. 81 (2020) 202-205].	Human Immunology	2020
32028812	Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?	Pediatric Hematology and Oncology	2020
32122686	A new set of reagents and related software used for NGS based classical and non-classical HLA typing showing evidence for a greater HLA haplotype diversity.	Human Immunology	2020
28629606	Evidence for a higher resolution of HLA genotyping by a new NGS-based approach.		2017
28506921	Decrease of blood anti-Î±1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients.	Clin Immunol	2017
26382919	Characterization of a new human monoclonal antibody directed against the Vel antigen.	Vox Sanguinis	2016
25522886	Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react.	British Journal of Haematology	2015
25441455	[Organization for the coverage of the transfusional needs of patients with hemoglobinopathy at the Ã¿tablissement franÃ§ais du sang Bretagne].		2015
24732592	High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial.	Leukemia	2014
22862853	Evaluation of CytoDiffâ¿¢ on cord blood WBC differential.	International Journal of Laboratory Hematology	2013
22015774	Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.	Leukemia	2012
22519920	Measures to prevent transfusion-related acute lung injury (TRALI).	Vox Sang	2012
19625380	Modulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive.	International Immunology	2009
19443257	[Platelet transfusion: products, indications, dose, threshold and efficacy].	Transfusion Clinique et Biologique	2009
18354419	IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.	Genes Immun	2008
18571003	Regulatory CD4+CD25hi T cells conserve their function and phenotype after granulocyte colony-stimulating factor treatment in human hematopoietic stem cell transplantation.	Human Immunology	2008
18615093	HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.	Genes Immun	2008
18241225	Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells.	Clinical and Experimental Immunology	2008
18606651	CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.	Journal of Immunology	2008
18760679	Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cells.	Clinical Immunology	2008
18417401	Use of random versus apheresis platelet concentrates.	Transfusion Clinique et Biologique	2007
17524696	[Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients].	Transfusion Clinique et Biologique	2007
17607189	[What's new in multiple sclerosis genetics?].	Revue Neurologique	2007
16934875	Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.	J Neuroimmunol	2006
16186815	A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility.	Nat Genet	2005
15961209	Regulation by allergens of chemokine receptor expression on in vitro-generated dendritic cells.	Toxicology	2005
15041160	Stimulation of peripheral blood and intestinal mucosa cells by synthetic CpG oligodeoxynucleotides.	Human Immunology	2004
15494893	A second-generation genomic screen for multiple sclerosis.	Am J Hum Genet	2004
15384976	Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas.	British Journal of Haematology	2004
15484187	Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression.	European Journal of Immunology	2004
14595552	Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study.	Neurogenetics	2004
15095853	NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis.	European Journal of Gastroenterology and Hepatology	2004
15014000	Performance characteristics of updated INNO-LiPA assays for molecular typing of human leukocyte antigen A (HLA-A), HLA-B, and HLA-DQB1 alleles.	Clinical and Diagnostic Laboratory Immunology	2004
12694585	Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.		2003
14551606	Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis.	Genes and Immunity	2003
12838528	Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.	Annals of Neurology	2003
12660582	[Synopsis of the conferences F. Lhermitte. Immunomodulation and induction of tolerance in MS].	Revue Neurologique	2003
14575918	Genetic analysis of multiple sclerosis in Europeans: French data.	Journal of Neuroimmunology	2003
12036896	Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction.	Blood	2002
11285127	HLA class I and class II allele and haplotype diversity in Martinicans.		2001
11566628	Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.	Eur Cytokine Netw	2001
11263767	Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.		2001
10919211	[Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].	Transfusion Clinique et Biologique	2000
10963076	Analysis of TNFalpha microsatellites in 35 patients with primary SjÃ¶gren's syndrome.	Joint Bone Spine	2000
11197688	No evidence for transmission disequilibrium between a new marker at the myelin basic protein locus and multiple sclerosis in French patients.	Genes and Immunity	2000
10330297	T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects.	J Autoimmun	1999
10323466	Environmental factors may modulate antiphospholipid antibody production in family members of patients with systemic lupus erythematosus.		1999
10371284	Positive association of the HLA DMB1*0101-0101 genotype with rheumatoid arthritis.	Rheumatology	1999
10210767	An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD).	European Cytokine Network	1999
10192454	Pregnancy-associated autoimmune neonatal thrombocytopenia: role of maternal HLA genotype.	British Journal of Haematology	1999